More than 47,000 people tested positive for the coronavirus on Saturday, about 1,000 more than a week before as the nation enters yet another wave of the pandemic.
The head of Korea's health authorities said Wednesday the unused doses of SKYCovione, a homegrown Covid-19 vaccine developed by SK Bioscience, will be likely discarded due to low demand.
The overall number of Covid-19 vaccines administered has risen dramatically, but so has the inequality of the distribution between developed and developing countries.
SK bioscience’s net profit fell more than 70 percent in the third quarter on the slowing demand for Covid-19 vaccines.
SK bioscience signed a memorandum of understanding (MOU) with New Delhi-based Hilleman Laboratories to co-develop vaccines for viral diseases.
On Tuesday, the Korean government started to administer an improved Covid-19 vaccine targeting the Omicron variant. Moderna’s bivalent vaccine is 69 percent more effective against the BA.5 subvariant of the Omicron strain.
Japan throws open its borders to individual tourists Tuesday, and Koreans are rushing to book tickets.
Inoculations of Korea's first domestically developed Covid-19 vaccine began Monday for individuals who made online reservations, a week after reservations were made available on Sept. 19.
Masks won't be required for outdoor group activities involving 50 people or more starting Monday, health authorities announced, lifting one of Korea's last remaining Covid restrictions.
SK bioscience applied to the World Health Organization (WHO) for an emergency use listing (EUL) for SKYCovione, the country's first domestically developed Covid-19 vaccine.